Última Hora: "Caso BPN. MP pede prisão efetiva para Arlindo de Carvalho e Oliveira e Costa - Diário de Notícias - Lisboa" Mon, 23 Oct 2017 17:21:36 GMT    "Uber escolhe Lisboa para instalar Centro de Excelência para a Europa - RTP" Mon, 23 Oct 2017 14:11:00 GMT    "Trabalhadores destacados vão ganhar o salário do país de acolhimento - Dinheiro Vivo" Mon, 23 Oct 2017 06:13:04 GMT   "?Por favor, não me compre a casa?. Casa de Ana Paula Guedes vai a leilão - Observador" Mon, 23 Oct 2017 20:27:04 GMT    "Programa para Dinamização Turística do Interior duplica orçamento - Notícias ao Minuto" Mon, 23 Oct 2017 18:55:17 GMT    "Anacom quer que Governo imponha uma redução preços entre 24% e 55% à Fibroglobal - Expresso" Mon, 23 Oct 2017 17:15:00 GMT    "Web Summit já vendeu 55 mil bilhetes com preços a chegar aos 1.500 euros - Expresso" Mon, 23 Oct 2017 17:55:00 GMT    "Há 238 cidades na América a competir pela sede da Amazon - Dinheiro Vivo" Mon, 23 Oct 2017 19:09:00 GMT    "OE2018: UTAO estima cativações de 1.776 ME e indica que 590 ME ficarão bloqueados - Dinheiro Vivo" Mon, 23 Oct 2017 15:48:18 GMT    "Governo diz que dados do IEFP dão confiança relativamente às metas traçadas no OE2018 - RTP" Mon, 23 Oct 2017 14:12:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

2022 Desloratadine Market Analysis, Attractiveness & Development with Key Players Mylan, Sepracor, Sandoz
Medgadget (blog)
... Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan Poly Pharm ...


ContraFect Appoints Lisa Ricciardi as Chief Operating Officer
GlobeNewswire (press release)
YONKERS, N.Y., Oct. 05, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

Asthma Medication Market ? Global Industry Size, Growth Analysis, Trends, Demand and Segment Forecast To 2022
Medgadget (blog)
Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks ...

e mais »

Form 8-K Kala Pharmaceuticals, For: Sep 28
StreetInsider.com
On September 28, 2017, the Board of Directors (the ?Board?) of Kala Pharmaceuticals, Inc. (the ?Company?) increased the size of the Board from eight to nine directors and, following the recommendation of the Nominating and Corporate Governance ...


Pediatric Internalizing Disorders: October 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Belgium's Ablynx enters the US market
PMLiVE
Dr Edwin Moses, CEO of Ablynx, said: "The establishment of Ablynx, Inc. is an important milestone for the Company and confirms our commitment to becoming a fully integrated international biopharmaceutical company. ?[Dan] brings many years of experience ...

e mais »

Global Asthma Medication Market Outlook by Product Overview, Application and Regions 2022
satPRnews (press release)
This Report Provides in depth survey of Asthma Medication Market using various Market Research Analysis.It also provides the details about the major Key Players in the market based on the quality of the products,profiling and financial report of industry.

e mais »

Asthma Medication Market Benefit and Volume 2017 with Status and Prospect to 2022
TS Global Market Updates (press release)
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The new vendor entrants in the market are finding it hard to compete with the international vendors based on ...


Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer
GlobeNewswire (press release)
CAMBRIDGE, Mass., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet ...

e mais »

Desloratadine Market Demand Analysis by Experts 2017 To 2022
Otaku Reports
Companies Profiled in this report includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters